Based on the data forecast for the import of Tetracyclines to India from 2024 to 2028, the volume is expected to rise steadily from 896.38 thousand kilograms in 2024 to 896.48 thousand kilograms in 2028. The year-on-year increase is relatively slight, indicating stability in import volumes with negligible percentage growth over these years. By comparison, in 2023, actual imports stood slightly lower, reflecting a minimal annual compound growth rate (CAGR) across this period.

Future trends to watch for:

Potential changes in Indian pharmaceutical regulations or policies affecting imports.
Fluctuations in global Tetracycline production impacting supply chains.
Shifts in market demand, possibly due to public health developments or alternative drug use.